 | • レポートコード：MRC2-11QY04171 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は粒子線治療のグローバル市場について調査・分析したレポートです。種類別（陽子線治療、重イオン治療）市場規模、用途別（小児がん、前立腺がん、乳がん、肺がん、頭頸部がん、その他のがん）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別粒子線治療の競争状況、市場シェア ・世界の粒子線治療市場：種類別市場規模 2015年-2020年（陽子線治療、重イオン治療） ・世界の粒子線治療市場：種類別市場規模予測 2021年-2026年（陽子線治療、重イオン治療） ・世界の粒子線治療市場：用途別市場規模 2015年-2020年（小児がん、前立腺がん、乳がん、肺がん、頭頸部がん、その他のがん） ・世界の粒子線治療市場：用途別市場規模予測 2021年-2026年（小児がん、前立腺がん、乳がん、肺がん、頭頸部がん、その他のがん） ・北米の粒子線治療市場分析：米国、カナダ ・ヨーロッパの粒子線治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの粒子線治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の粒子線治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの粒子線治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Varian Medical Systems、Ion Beam Applications Sa (IBA)、Mevion Medical Systems, Inc.、Provision Healthcare, LLC、Sumitomo Heavy Industries, Ltd.、Hitachi, Ltd.、Optivus Proton Therapy, Inc.、Protom International, Inc.、Advanced Oncotherapy PLC.、Danfysik A/S ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy is proton therapy.
Market Analysis and Insights: Global Particle Therapy Market
The global Particle Therapy market size is projected to reach US$ 812.7 million by 2026, from US$ 768.8 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Particle Therapy Scope and Market Size
Particle Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Particle Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Varian Medical Systems
Ion Beam Applications Sa (IBA)
Mevion Medical Systems, Inc.
Provision Healthcare, LLC
Sumitomo Heavy Industries, Ltd.
Hitachi, Ltd.
Optivus Proton Therapy, Inc.
Protom International, Inc.
Advanced Oncotherapy PLC.
Danfysik A/S
Market segment by Type, the product can be split into
Proton Therapy
Heavy Ion Therapy
Market segment by Application, split into
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Particle Therapy Revenue
1.4 Market by Type
1.4.1 Global Particle Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Proton Therapy
1.4.3 Heavy Ion Therapy
1.5 Market by Application
1.5.1 Global Particle Therapy Market Share by Application: 2020 VS 2026
1.5.2 Pediatric Cancer
1.5.3 Prostate Cancer
1.5.4 Breast Cancer
1.5.5 Lung Cancer
1.5.6 Head and Neck Cancer
1.5.7 Other Cancers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Particle Therapy Market Perspective (2015-2026)
2.2 Global Particle Therapy Growth Trends by Regions
2.2.1 Particle Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Particle Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Particle Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Particle Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Particle Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Particle Therapy Players by Market Size
3.1.1 Global Top Particle Therapy Players by Revenue (2015-2020)
3.1.2 Global Particle Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Particle Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Particle Therapy Market Concentration Ratio
3.2.1 Global Particle Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Particle Therapy Revenue in 2019
3.3 Particle Therapy Key Players Head office and Area Served
3.4 Key Players Particle Therapy Product Solution and Service
3.5 Date of Enter into Particle Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Particle Therapy Historic Market Size by Type (2015-2020)
4.2 Global Particle Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Particle Therapy Market Size by Application (2015-2020)
5.2 Global Particle Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Particle Therapy Market Size (2015-2020)
6.2 Particle Therapy Key Players in North America (2019-2020)
6.3 North America Particle Therapy Market Size by Type (2015-2020)
6.4 North America Particle Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Particle Therapy Market Size (2015-2020)
7.2 Particle Therapy Key Players in Europe (2019-2020)
7.3 Europe Particle Therapy Market Size by Type (2015-2020)
7.4 Europe Particle Therapy Market Size by Application (2015-2020)
8 China
8.1 China Particle Therapy Market Size (2015-2020)
8.2 Particle Therapy Key Players in China (2019-2020)
8.3 China Particle Therapy Market Size by Type (2015-2020)
8.4 China Particle Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Particle Therapy Market Size (2015-2020)
9.2 Particle Therapy Key Players in Japan (2019-2020)
9.3 Japan Particle Therapy Market Size by Type (2015-2020)
9.4 Japan Particle Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Particle Therapy Market Size (2015-2020)
10.2 Particle Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Particle Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Particle Therapy Market Size by Application (2015-2020)
11 India
11.1 India Particle Therapy Market Size (2015-2020)
11.2 Particle Therapy Key Players in India (2019-2020)
11.3 India Particle Therapy Market Size by Type (2015-2020)
11.4 India Particle Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Particle Therapy Market Size (2015-2020)
12.2 Particle Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Particle Therapy Market Size by Type (2015-2020)
12.4 Central & South America Particle Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Varian Medical Systems
13.1.1 Varian Medical Systems Company Details
13.1.2 Varian Medical Systems Business Overview
13.1.3 Varian Medical Systems Particle Therapy Introduction
13.1.4 Varian Medical Systems Revenue in Particle Therapy Business (2015-2020))
13.1.5 Varian Medical Systems Recent Development
13.2 Ion Beam Applications Sa (IBA)
13.2.1 Ion Beam Applications Sa (IBA) Company Details
13.2.2 Ion Beam Applications Sa (IBA) Business Overview
13.2.3 Ion Beam Applications Sa (IBA) Particle Therapy Introduction
13.2.4 Ion Beam Applications Sa (IBA) Revenue in Particle Therapy Business (2015-2020)
13.2.5 Ion Beam Applications Sa (IBA) Recent Development
13.3 Mevion Medical Systems, Inc.
13.3.1 Mevion Medical Systems, Inc. Company Details
13.3.2 Mevion Medical Systems, Inc. Business Overview
13.3.3 Mevion Medical Systems, Inc. Particle Therapy Introduction
13.3.4 Mevion Medical Systems, Inc. Revenue in Particle Therapy Business (2015-2020)
13.3.5 Mevion Medical Systems, Inc. Recent Development
13.4 Provision Healthcare, LLC
13.4.1 Provision Healthcare, LLC Company Details
13.4.2 Provision Healthcare, LLC Business Overview
13.4.3 Provision Healthcare, LLC Particle Therapy Introduction
13.4.4 Provision Healthcare, LLC Revenue in Particle Therapy Business (2015-2020)
13.4.5 Provision Healthcare, LLC Recent Development
13.5 Sumitomo Heavy Industries, Ltd.
13.5.1 Sumitomo Heavy Industries, Ltd. Company Details
13.5.2 Sumitomo Heavy Industries, Ltd. Business Overview
13.5.3 Sumitomo Heavy Industries, Ltd. Particle Therapy Introduction
13.5.4 Sumitomo Heavy Industries, Ltd. Revenue in Particle Therapy Business (2015-2020)
13.5.5 Sumitomo Heavy Industries, Ltd. Recent Development
13.6 Hitachi, Ltd.
13.6.1 Hitachi, Ltd. Company Details
13.6.2 Hitachi, Ltd. Business Overview
13.6.3 Hitachi, Ltd. Particle Therapy Introduction
13.6.4 Hitachi, Ltd. Revenue in Particle Therapy Business (2015-2020)
13.6.5 Hitachi, Ltd. Recent Development
13.7 Optivus Proton Therapy, Inc.
13.7.1 Optivus Proton Therapy, Inc. Company Details
13.7.2 Optivus Proton Therapy, Inc. Business Overview
13.7.3 Optivus Proton Therapy, Inc. Particle Therapy Introduction
13.7.4 Optivus Proton Therapy, Inc. Revenue in Particle Therapy Business (2015-2020)
13.7.5 Optivus Proton Therapy, Inc. Recent Development
13.8 Protom International, Inc.
13.8.1 Protom International, Inc. Company Details
13.8.2 Protom International, Inc. Business Overview
13.8.3 Protom International, Inc. Particle Therapy Introduction
13.8.4 Protom International, Inc. Revenue in Particle Therapy Business (2015-2020)
13.8.5 Protom International, Inc. Recent Development
13.9 Advanced Oncotherapy PLC.
13.9.1 Advanced Oncotherapy PLC. Company Details
13.9.2 Advanced Oncotherapy PLC. Business Overview
13.9.3 Advanced Oncotherapy PLC. Particle Therapy Introduction
13.9.4 Advanced Oncotherapy PLC. Revenue in Particle Therapy Business (2015-2020)
13.9.5 Advanced Oncotherapy PLC. Recent Development
13.10 Danfysik A/S
13.10.1 Danfysik A/S Company Details
13.10.2 Danfysik A/S Business Overview
13.10.3 Danfysik A/S Particle Therapy Introduction
13.10.4 Danfysik A/S Revenue in Particle Therapy Business (2015-2020)
13.10.5 Danfysik A/S Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Particle Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Particle Therapy Revenue
Table 3. Ranking of Global Top Particle Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Particle Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Proton Therapy
Table 6. Key Players of Heavy Ion Therapy
Table 7. Global Particle Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Particle Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Particle Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Particle Therapy Market Share by Regions (2015-2020)
Table 11. Global Particle Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Particle Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Particle Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Particle Therapy Players
Table 18. Global Particle Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Particle Therapy Market Share by Players (2015-2020)
Table 20. Global Top Particle Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Particle Therapy as of 2019)
Table 21. Global Particle Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Particle Therapy Product Solution and Service
Table 24. Date of Enter into Particle Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Particle Therapy Market Size Share by Type (2015-2020)
Table 28. Global Particle Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Particle Therapy Market Size Share by Application (2015-2020)
Table 30. Global Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Particle Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Particle Therapy Market Share (2019-2020)
Table 34. North America Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Particle Therapy Market Share by Type (2015-2020)
Table 36. North America Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Particle Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Particle Therapy Market Share (2019-2020)
Table 40. Europe Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Particle Therapy Market Share by Type (2015-2020)
Table 42. Europe Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Particle Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Particle Therapy Market Share (2019-2020)
Table 46. China Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Particle Therapy Market Share by Type (2015-2020)
Table 48. China Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Particle Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Particle Therapy Market Share (2019-2020)
Table 52. Japan Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Particle Therapy Market Share by Type (2015-2020)
Table 54. Japan Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Particle Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Particle Therapy Market Share (2019-2020)
Table 58. Southeast Asia Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Particle Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Particle Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Particle Therapy Market Share (2019-2020)
Table 64. India Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Particle Therapy Market Share by Type (2015-2020)
Table 66. India Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Particle Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Particle Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Particle Therapy Market Share (2019-2020)
Table 70. Central & South America Particle Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Particle Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Particle Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Particle Therapy Market Share by Application (2015-2020)
Table 74. Varian Medical Systems Company Details
Table 75. Varian Medical Systems Business Overview
Table 76. Varian Medical Systems Product
Table 77. Varian Medical Systems Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 78. Varian Medical Systems Recent Development
Table 79. Ion Beam Applications Sa (IBA) Company Details
Table 80. Ion Beam Applications Sa (IBA) Business Overview
Table 81. Ion Beam Applications Sa (IBA) Product
Table 82. Ion Beam Applications Sa (IBA) Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 83. Ion Beam Applications Sa (IBA) Recent Development
Table 84. Mevion Medical Systems, Inc. Company Details
Table 85. Mevion Medical Systems, Inc. Business Overview
Table 86. Mevion Medical Systems, Inc. Product
Table 87. Mevion Medical Systems, Inc. Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 88. Mevion Medical Systems, Inc. Recent Development
Table 89. Provision Healthcare, LLC Company Details
Table 90. Provision Healthcare, LLC Business Overview
Table 91. Provision Healthcare, LLC Product
Table 92. Provision Healthcare, LLC Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 93. Provision Healthcare, LLC Recent Development
Table 94. Sumitomo Heavy Industries, Ltd. Company Details
Table 95. Sumitomo Heavy Industries, Ltd. Business Overview
Table 96. Sumitomo Heavy Industries, Ltd. Product
Table 97. Sumitomo Heavy Industries, Ltd. Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 98. Sumitomo Heavy Industries, Ltd. Recent Development
Table 99. Hitachi, Ltd. Company Details
Table 100. Hitachi, Ltd. Business Overview
Table 101. Hitachi, Ltd. Product
Table 102. Hitachi, Ltd. Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 103. Hitachi, Ltd. Recent Development
Table 104. Optivus Proton Therapy, Inc. Company Details
Table 105. Optivus Proton Therapy, Inc. Business Overview
Table 106. Optivus Proton Therapy, Inc. Product
Table 107. Optivus Proton Therapy, Inc. Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 108. Optivus Proton Therapy, Inc. Recent Development
Table 109. Protom International, Inc. Business Overview
Table 110. Protom International, Inc. Product
Table 111. Protom International, Inc. Company Details
Table 112. Protom International, Inc. Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 113. Protom International, Inc. Recent Development
Table 114. Advanced Oncotherapy PLC. Company Details
Table 115. Advanced Oncotherapy PLC. Business Overview
Table 116. Advanced Oncotherapy PLC. Product
Table 117. Advanced Oncotherapy PLC. Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 118. Advanced Oncotherapy PLC. Recent Development
Table 119. Danfysik A/S Company Details
Table 120. Danfysik A/S Business Overview
Table 121. Danfysik A/S Product
Table 122. Danfysik A/S Revenue in Particle Therapy Business (2015-2020) (Million US$)
Table 123. Danfysik A/S Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Particle Therapy Market Share by Type: 2020 VS 2026
Figure 2. Proton Therapy Features
Figure 3. Heavy Ion Therapy Features
Figure 4. Global Particle Therapy Market Share by Application: 2020 VS 2026
Figure 5. Pediatric Cancer Case Studies
Figure 6. Prostate Cancer Case Studies
Figure 7. Breast Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Head and Neck Cancer Case Studies
Figure 10. Other Cancers Case Studies
Figure 11. Particle Therapy Report Years Considered
Figure 12. Global Particle Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Particle Therapy Market Share by Regions: 2020 VS 2026
Figure 14. Global Particle Therapy Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Particle Therapy Market Share by Players in 2019
Figure 17. Global Top Particle Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Particle Therapy as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Particle Therapy Revenue in 2019
Figure 19. North America Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Particle Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
陽子線治療の世界市場（～2026年） Ionizing radiations are used to treat cancer and the procedure is known as radiation therapy. When the ionizing radiations are made up of charged particles such as protons, carbon, and other ions, then radiation therapy is called as hadron therapy. Market Analysis and Insights: Global Proton Therapy…- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- がん遺伝子治療の世界市場（～2026年） Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…